Healthcare was the best performing sector in the second quarter with a 6.3% return, and not far behind tech sector looking at the year-to-date performance. The sector has been outperforming the broader market despite the uncertainty surrounding Trump administration's plans to repeal and replace Obamacare.
Healthcare stocks have rallied mainly in anticipation of a favorable policy environment. The Trump administration plans to focus on easing regulatory hurdles rather than lowering drug prices, according to a draft executive order obtained by the New York Times. Investors also expect a streamlined and faster drug approval process.
Further, some investors rotated out of pricier tech stocks into healthcare stocks. These stocks were beaten down over the past two years. After trailing the broader market over the past so many months, healthcare sector valuations looked quite attractive.
The longer-term outlook for healthcare remains positive as the sector is a direct beneficiary of the world's rapidly aging demographic trend. Further, in many developing countries, governments are increasing their healthcare support. And in these countries, healthcare spending is rising from a very low level and has a significant potential to go up as income levels in these countries rise.
Healthcare is a defensive sector and could be a good bet for those worried about rising geopolitical uncertainty. Further, historically healthcare has outperformed the broader market during a period of rising interest rates.
Within the broader healthcare sector, biotech stocks are the best performers of late. But given the volatility associated with biotech stocks, they are more suitable for investors with high-risk tolerance. For long-term investors, ultra-cheap broad healthcare ETFs that are currently ranked Zacks Rank #1 (Strong Buy) are more suitable.
To learn more about the SPDR Health Care Select Sector ETF XLV and the Vanguard Health Care ETF VHT, please watch the short video above.
Today's Stocks from Zacks' Hottest Strategies It's hard to believe, even for us at Zacks. But while the market gained +18.8% from 2016 - Q1 2017, our top stock-picking screens have returned +157.0%, +128.0%, +97.8%, +94.7%, and +90.2% respectively. And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - Q1 2017, the composite yearly average gain for these strategies has beaten the market more than 11X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation. See Them Free>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
SPDR-SP 500 TR SPY: ETF Research Reports
SPDR-HLTH CR XLV: ETF Research Reports
VIPERS-HLTH CR VHT: ETF Research Reports
To read this article on Zacks.com click here.
Zacks Investment Research
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
